Substituted guanidine derivatives

US6503912B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Klaus Wagner · Warthausen, DE
• Christoph Erdelen · Leichlingen, DE
• Wolfram Andersch · Bensberg, DE
• Ulrike Wachendorff-Neumann · Neuwied, DE
• Andreas Turberg · Haan, DE
• Norbert Mencke · Leverkusen, DE

Key dates

• Filing date: Jun 28, 2000
• Grant date: Jan 7, 2003
• Expiry date: Jun 28, 2020

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/06
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present application relates to novel guanidine derivatives of the formula (I) in whichR1 represents a five- or six-membered heterocyclic group;R2 represents hydrogen or alkyl,R3 represents the groupings —OR4, —OCOR5, —OCOOR6, —OCONR7R8 and —OSO2R9, whereR4, R5 and R6 independently of one another represent alkyl, alkoxyalkyl, halogenoalkyl, alkenyl, alkinyl, alkylaminoalkyl, dialkylaminoalkyl, optionally substituted cycloalkyl and in each case optionally substituted phenyl or benzyl,R7 and R8 independently of one another represent hydrogen, alkyl, alkenyl and in each case optionally substituted phenyl or benzyl andR9 represents alkyl or optionally substituted phenyl,A represents the groupings —CH2CH2—, (CH2)3 and —CH═CH— andz represents cyano or nitro,with the proviso that, if Z represents NO2 and A represents —CH2CH2—, the radical R2 represents hydrogen; and the compound of the formula (I) in whichR1R2 H,R3 OCH3,A —CH2CH2— andZ NO2 is excluded.The compounds serve for controlling insects, arachnids and nematodes.